MedTrace Logo

The Effect of the Ideal Food Pyramid on Rheumatoid Arthritis

NCT06621927 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-10-01

No results posted yet for this study

Summary

The aim of this study was to observe the effects of the Ideal Food Pyramid created for Rheumatoid Arthritis patients on disease activity, inflammatory markers, body composition and intestinal microbiota. The main questions it aims to answer are:

* Does the Ideal Food Pyramid improve dysbiosis in patients with rheumatoid arthritis?
* Does the Ideal Food Pyramid improve clinical and laboratory findings in patients with rheumatoid arthritis? Researchers will compare the Ideal Food Pyramid with a control group (no intervention) to determine if it has an effect on rheumatoid arthritis.

Participants:

All participants will fill out questionnaires at the beginning of the study, blood and stool will be collected. These procedures will be repeated at the end of the study.

Diet or control (no intervention) will be applied for 12 weeks Diet group will be checked for compliance with the diet every 2 weeks

Conditions

  • Rheumatoid Arthritis (RA)

Interventions

OTHER

Diet

The Ideal Food Pyramid, which has not been applied before, is used to observe disease activities and especially changes in intestinal microbiota in rheumatoid arthritis.

OTHER

Control (Standard treatment)

We chose a control group to show the effect of the intervention we would apply to the diet group and did not apply any intervention to the control group.

Sponsors & Collaborators

  • TC Erciyes University

    lead OTHER

Principal Investigators

  • Ülger Kaçar Mutlutürk · Erciyes University Medical Faculty Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-20
Primary Completion
2024-04-20
Completion
2024-06-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06621927 on ClinicalTrials.gov